Gene · 8843
Papers3,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,413
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic medicine in hepatology: mechanisms and liver treatment strategies. | Mol Med | 2025 | 41023586 | PubTator, text mining | PubMed |
| Structure Modeling and Virtual Screening with HCAR3 to Discover Potential Therapeutic Molecules. | Pharmaceuticals (Basel) | 2025 | 41011161 | PubTator, text mining | PubMed |
| [Septin9 promotes viral replication by interacting with Ebola virus VP35 to regulate inclusion body formation]. | Sheng Wu Gong Cheng Xue Bao | 2025 | 40873324 | PubTator, text mining | PubMed |
| HCAR3 May Mediate Autism Symptoms: Evidence From RNA-Sequencing of Peripheral Blood Mononuclear Cells. | Psychiatry Investig | 2025 | 40738169 | PubTator, text mining | PubMed |
| HCAR3 and Kynurenic Acid in Cancer: A Promising Axis of Immunometabolic Regulation or a Scientific Mirage? | Int J Mol Sci | 2025 | 40650047 | PubTator, text mining | PubMed |
| Evaluation of epigenetic silencing of the miR-139-5p gene in the pathogenesis of colorectal cancer and its diagnostic biomarker capability in plasma samples. | BMC Cancer | 2025 | 40375170 | PubTator, text mining | PubMed |
| Drug Repurposing to Inhibit Oncostatin M in Crohn's Disease. | Molecules | 2025 | 40363705 | PubTator, text mining | PubMed |
| Activation and signaling characteristics of the hydroxy-carboxylic acid 3 receptor identified in human neutrophils through a microfluidic flow cell technique. | Biochim Biophys Acta Mol Cell Res | 2025 | 40194600 | PubTator, text mining | PubMed |
| A cellular assay to determine the fusion capacity of MFN2 variants linked to Charcot-Marie-Tooth disease of type 2 A. | Sci Rep | 2025 | 40121276 | PubTator, text mining | PubMed |
| Insights on the crosstalk among different cell death mechanisms. | Cell Death Discov | 2025 | 39929794 | PubTator, text mining | PubMed |
| GTPBP8 mitigates nonalcoholic steatohepatitis (NASH) by depressing hepatic oxidative stress and mitochondrial dysfunction via PGC-1α signaling. | Free Radic Biol Med | 2025 | 39341301 | PubTator, text mining | PubMed |
| Rab3B Proteins: Cellular Functions, Regulatory Mechanisms, and Potential as a Cancer Therapy Target. | Cell Biochem Biophys | 2025 | 39320613 | PubTator, text mining | PubMed |
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| Using artificial intelligence and promoter-level transcriptome analysis to identify a biomarker as a possible prognostic predictor of cardiac complications in male patients with Fabry disease. | Mol Genet Metab Rep | 2024 | 39484074 | PubTator, text mining | PubMed |
| Structural basis for ligand recognition of the human hydroxycarboxylic acid receptor HCAR3. | Cell Rep | 2024 | 39427321 | Swiss-Prot, curated | PubMed |
| Relationship between GTP binding protein RAB10, toll-like receptor 4, and nuclear factor kappa-B and prognosis in patients with breast cancer. | Sci Rep | 2024 | 39375417 | PubTator, text mining | PubMed |
| Identification of New Potential Targets for Pancreatic Ductal Adenocarcinoma by Integrated Bioinformatic Analysis. | Anticancer Res | 2024 | 39348994 | PubTator, text mining | PubMed |
| Detection of TurboID fusion proteins by fluorescent streptavidin outcompetes antibody signals and visualises targets not accessible to antibodies. | Elife | 2024 | 39206942 | PubTator, text mining | PubMed |
| Evaluating the significance of ECSCR in the diagnosis of ulcerative colitis and drug efficacy assessment. | Front Immunol | 2024 | 39170615 | PubTator, text mining | PubMed |
| Insights into Calpain Activation and Rho-ROCK Signaling in Parkinson's Disease and Aging. | Biomedicines | 2024 | 38791036 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8843/papers?page=2